Study participation improves treatment strategies and individual patient care in participating centers

Anticancer Research

Volumn 26, Issue 5 B, 2006, Pages 3661-3667

  Janni, Wolfgang ^a,f   Kiechle, M ^b   Sommer, H ^a   Rack, B ^a   Gauger, K ^b   Heinrigs, M ^a   Steinfeld, D ^c   Augustin, D ^d   Simon, W ^e   Harbeck, N ^b   Friese, K ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c KLINIKUM AUGSBURG   (Germany)

^d Mammazentrum Ostbayern   (Germany)

^e ROBERT BOSCH HOSPITAL   (Germany)

^f I Frauenklinik Innenstadt   (Germany)

Author keywords

Breast cancer; Cancer recurrence; Metastasis; Prognosis; Study participation

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RESEARCH; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEDICAL CARE; MEDICAL INFORMATION; PATIENT CARE; PATIENT PARTICIPATION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; QUESTIONNAIRE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; PROSPECTIVE STUDIES; QUESTIONNAIRES; TAXOIDS; TREATMENT OUTCOME;

EID: 33750719973     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Early Breast Cancer Trialists' Collaborative Group: Ovarian Ablation for Early Breast Cancer. Cochrane Database Syst Rev CD000485, 2000.
2. Tamoxifen for Early Breast Cancer. Cochrane Database Syst Rev CD000486, 2001.
3. Beatson GT: On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases. Lancet 74: 1896.
4. Berger A: High dose chemotherapy offers little benefit in breast cancer. BMJ 318: 1440, 1999.
5. Blichert TM, Rose C, Andersen JA, Overgaard M, Axelsson CK, Andersen KW and Mouridsen HT: Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 11: 19-25, 1992.
6. Bonadonna G and Valagussa P: Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 304: 10-15, 1981.
7. Dixon JR Jr: The International Conference on Harmonization Good Clinical Practice Guideline. Qual Assur 6: 65-74, 1998.
8. du Bois A, Rochon J, Lamparter C and Pfisterer J: Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer. Int J Gynecol Cancer 15: 183-191, 2005.
9. Early Breast Cancer Trialists' Collaborative Group: Multi-agent chemotherapy for early breast cancer. Cochrane Database Syst Rev CD000487, 2002.
10. Einhorn LH: Ifosfamide in germ cell tumors. Oncology 65: 73-75, 2003.
11. Farquhar C, Basser R, Hetrick S, Lethaby A and Marjoribanks J: High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer. Cochrane Database Syst Rev CD003142, 2003.
12. Farquhar C, Basser R, Marjoribanks J and Lethaby A: High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer. Cochrane Database Syst Rev CD003139, 2003.
13. Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, Fisher E, Deutsch M, Caplan R, Pilch Y et al: Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 520: 822-828, 1989.
14. Gnant M: Impact of participation in randomized clinical trials on survival of women with early-stage breast cancer - an analysis of 7985 patients. Proc ASCO. 2000. (Abstract)
15. Halsted WS: The results of radical operation for the cure of carcinoma of the breast. Ann Surg 46: 1-19, 1907.
16. Harter P, Du Bois A, Schade-Brittinger C, Burges A, Wollschlaeger K, Gropp M, Schmalfeldt B, Huober J, Staehle A and Pfisterer J: Non-enrolment of ovarian cancer patients in clinical trials: reasons and background. Ann Oncol, 2005.
17. Hebert-Croteau N, Brisson J, Lemaire J and Latreille J: The benefit of participating to clinical research. Breast Cancer Res Treat 91: 279-281, 2005.
18. Jacobson JA, Danforth DN, Cowan KH, d'Angelo T, Steinberg SM, Pierce L, Lippman ME, Lichter AS, Glatstein E and Okunieff P: Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 332: 907-911, 1995.
19. Janni W, Rack B, Schindlbeck C, Strobl B, Rjosk D, Braun S, Sommer H, Pantel K, Gerber B and Friese K: Association of persistence of isolated tumor cells (ITC) in bone marrow (BM) of breast cancer patients with risk for relapse. Proc ASCO, 2004 (Abstract).
20. Janni W, Rjosk D, Dimpfl TH, Haertl K, Strobl B, Hepp F, Hanke A, Bergauer F and Sommer H: Quality of life influenced by primary surgical treatment for stage I-III breast cancer-long-term follow-up of a matched-pair analysis. Ann Surg Oncol 8: 542-548, 2001.
21. Janni W, Sommer H, Strobl B, Rack B, Klanner E, Hantschmann P, Rammel G, Harms G and Dimpfl T: Progress in the early diagnosis of breast carcinoma during the years 1981-1990. Results of a longitudinal study. Dtsch Med Wochenschr 128: 601-606, 2003.
22. Kuhn T, Bembenek A, Buchels H, Decker T, Dunst J, Mullerleile U, Munz DL, Ostertag H, Sautter-Bihl ML, Schirrmeister H, Tulusan AH, Untch M, Winzer KJ and Wittekind C: Sentinel node biopsy in breast carcinoma. Interdisciplinary agreement consensus of the German Society for Serology for quality controlled application in routine clinical testing. Pathologe 25: 238-243, 2004.
23. Minter RM, Spengler KK, Topping DP, Flug R, Copeland EM and Lind DS: Institutional validation of breast cancer treatment guidelines. J Surg Res 100: 106-109, 2001.
24. Pantel K and Brakenhoff RH: Dissecting the metastatic cascade. Nat Rev Cancer 4: 448-456, 2004.
25. Peppercorn JM, Weeks JC, Cook EF and Joffe S: Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet 363: 263-270, 2004.
26. Peto R: 2003 (personal communication).
27. Rahman ZU, Frye DK, Buzdar AU, Smith TL, Asmar L, Champlin RE and Hortobagyi GN: Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer. J Clin Oncol 15: 3171-3177, 1997.
28. Randal J: Study evaluates information on breast cancer Web sites. J Natl Cancer Inst 96: 430, 2004.
29. Sarrazin D, Le MG, Arriagada R, Contesso G, Fontaine F, Spielmann M, Rochard F, Le-Chevalier T and Lacour J: Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 14: 177-184, 1989.
30. Sehouli J, Kostromitskaia J, Stengel D and Du Bois A: Why institutions do not participate in ovarian cancer trials - results from a survey in Germany. Onkologie 28: 13-17, 2005.
31. Stiller CA: Centralised treatment, entry to trials and survival. Br J Cancer 70: 352-362, 1994.
32. Thornton H: Evidence-based information. Lancet 353: 2249, 1999.
33. van-Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van-der-Schueren E, Sylvester R, Winter J and van-Zijl K: Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr 15-18, 1992.
34. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, Robertson C, Sacchini V, Veronesi P, Orvieto E, De Cicco C, Intra M, Tosi G and Scarpa D: Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 91: 368-373, 1999.
35. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F and Gennari R: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349: 546-553, 2003.
36. Veronesi U, Salvadori B, Luini A, Greco M, Saccozzi R, Del-Vecchio M, Mariani L, Zurrida S and Rilke F: Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. Eur J Cancer 31A: 1574-1579, 1995.
37. Veronesi U and Zurrida S: Present and future of sentinel node lymphadenectomy in breast cancer. Recent Results Cancer Res 157: 221-227, 2000.
38. von Minckwitz G, Brunnert K, Costa SD, Friedrichs K, Jackisch C, Gerber B, Harbeck N, Junkermann H, Mobus V, Nitz U, Schaller G, Scharl A, Thomssen C and Untch M: Evidence-based recommendations on primary treatment of carcinomas of the breast. Zentralbl Gynakol 124: 293-303, 2002.
39. Ward LC, Fielding JW, Dunn JA and Kelly KA: The selection of cases for randomised trials: a registry survey of concurrent trial and non-trial patients. The British Stomach Cancer Group. Br J Cancer 66: 943-950, 1992.